Results
|
178681.
|
|
|
178682.
|
|
|
178683.
|
|
|
178684.
|
|
|
178685.
|
|
|
178686.
|
|
|
178687.
|
|
|
178688.
|
|
|
178689.
|
|
|
178690.
|
|
|
178691.
|
|
|
178692.
|
|
|
178693.
|
|
|
178694.
|
Extended (Every 12 Weeks or Longer) Dosing Interval With Intravitreal Aflibercept and Ranibizumab in Neovascular Age-Related Macular Degeneration: Post Hoc Analysis of VIEW Trials. [electronic resource] by
- Khurana, Rahul N
- Rahimy, Ehsan
- Joseph, W Anthony
- Saroj, Namrata
- Gibson, Andrea
- Vitti, Robert
- Berliner, Alyson J
- Chu, Karen
- Cheng, YenChieh
- Boyer, David S
Producer: 20191213
In:
American journal of ophthalmology vol. 200
Availability: No items available.
|
|
178695.
|
|
|
178696.
|
|
|
178697.
|
|
|
178698.
|
|
|
178699.
|
|
|
178700.
|
|